If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. A new type of drug-free nasal spray could be a great defense against Covid-19, the ...

The makers of a nasal spray launched last year by start-up Akita Biosciences have pulled back the curtain on how their product works (Adv. Mater. 2024, DOI: 10.1002/adma.202406348). The company ...

A potential new defense may have appeared in the form of a commercially available nasal spray built from a collection of readily available and inactive chemical ingredients. According to results ...

New research published in Advanced Materials reports a novel nasal spray for preventing respiratory infections. The spray works by forming a protective coating on the nasal cavity, which captures ...

BOSTON — A new study found a new drug-free nasal spray may protect against respiratory infections like COVID and the flu, ...

Pathogens inhaled along with respiratory droplets enter through the nasal lining, causing respiratory infections. Brigham researchers have developed a pathogen capture and neutralizing spray ...

A non-drug nasal spray could theoretically help stop the spread of respiratory viruses like the flu and COVID-19 better than wearing a mask, a new study suggests. The spray uses ingredients that ...

especially in a world where vaccines and masks alone may not suffice. This innovative nasal spray could soon become a powerful defense against various pathogens.

Based on their preclinical studies, the researchers say the broad-spectrum nasal spray is long-lasting, safe, and, if validated in humans, could play a key role in reducing respiratory diseases ...

A study has shown that a new nasal spray could neutralise germs in the nose, preventing infection. The pathogen capture and neutralising spray, or PCANS, is a nasal spray that could shield us from ...

Support us to deliver journalism without an agenda. The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver.

The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver. FluMist, produced by European pharmaceutical company ...